Thus, PCD may be reasonably excluded in patients with bronchiectasis and repeatedly normal nNO levels and VUS in PCD genes with known associated ciliary ultrastructural defects as well as reduced nNO, if TEM unequivocally demonstrates normal findings. This evidence concerns the gene DNAI1 and bronchiectasis.